The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Diabetes and cancer
Open accessAbstract
Diabetes and cancer are two heterogeneous, multifactorial, severe, and chronic diseases. Because of their frequency, reciprocal influences - even minor influences - may have a major impact. Epidemiological studies clearly indicate that the risk of several types of cancer (including pancreas, liver, breast, colorectal, urinary tract, and female reproductive organs) is increased in diabetic patients. Mortality is also moderately increased. Several confounding factors, having general or site-specific relevance, make it difficult to accurately assess cancer risk in diabetic patients. These factors include diabetes duration, varying levels of metabolic control, different drugs used for therapy, and the possible presence of chronic complications. Hyperinsulinemia most likely favors cancer in diabetic patients as insulin is a growth factor with pre-eminent metabolic but also mitogenic effects, and its action in malignant cells is favored by mechanisms acting at both the receptor and post-receptor level. Obesity, hyperglycemia, and increased oxidative stress may also contribute to increased cancer risk in diabetes. While anti-diabetic drugs have a minor influence on cancer risk (except perhaps the biguanide metformin that apparently reduces the risk), drugs used to treat cancer may either cause diabetes or worsen a pre-existing diabetes. In addition to the well-known diabetogenic effect of glucocorticoids and anti-androgens, an increasing number of targeted anti-cancer molecules may interfere with glucose metabolism acting at different levels on the signaling substrates shared by IGF-I and insulin receptors. In conclusion, diabetes and cancer have a complex relationship that requires more clinical attention and better-designed studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetes is associated with reduced risk of prostate cancer.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Diabetes (primarily type 2) is associated with increased risk for some cancers (liver, pancreas, endometrium, colon and rectum, breast, bladder).”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Epidemiologic evidence suggests that people with diabetes are at significantly higher risk for many forms of cancer.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“For some other cancer sites there appears to be no association or the evidence is inconclusive.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Other cancers (e.g., lung) do not appear to be associated with an increased risk in diabetes, and the evidence for others (e.g., kidney, non-Hodgkin lymphoma) is inconclusive.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“The relative risks imparted by diabetes are greatest (about twofold or higher) for cancers of the liver, pancreas, and endometrium, and lesser (about 1.2–1.5 fold) for cancers of the colon and rectum, breast, and bladder.”
From Diabetes and Cancer (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(1911) · JAMA · doi:10.1001/jama.1911.04260070032017 · Cited by 3,355
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.80003397.x · Cited by 2,202
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Archives of Biochemistry and Biophysics
Carter, H. E., Bhattacharyya, P., Weidman, K. R., & Fraenkel, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06727.x · Cited by 1,895
Flagged first, then by citations
Research works printed but not linked: 1
- Lindblad P Adami HO 2002 Kidney cancer. In Textbook of Cancer Epidemiology, pp 467–485 Eds HunterDAdamiHOTrichopoulosD. New York: Oxford University Press.
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Diabetes und Karzinomrisiko des Verdauungstrakts: Update 2012
Jf, R. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Raynor, L. A. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Göke, B., de Heer, J., Nagel, J. M., & Göke, R. (2014) · Der Diabetologe · doi:10.1007/s11428-014-1207-7
Register studies of cancer in the Southern Health Care Region in Sweden
Attner, B. (2012) · Lund University Publications (Lund University)
Pharmacotherapy of diabetes and cancer risk
Kaku, K., & Hashiramoto, M. (2011) · Diabetology International · doi:10.1007/s13340-011-0043-x
Links among type 2 diabetes, cancer and metformin use: What have we learned?
Sheen, Y., & Sheu, W. H. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.03.014
The mitogenicity of insulin analogues in vitro relative to insulin and IGF‐I—Response to Kazda et al
Weinstein, D., Simon, M., Yehezkel, E., Laron, Z., & Werner, H. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1096
Dedov, I. I., Бутрова, С. А., & Berkovskaya, M. A. (2011) · Obesity and metabolism · doi:10.14341/2071-8713-5190
Pourquoi les diabétiques ont-ils un risque plus important de développer un cancer ?
Buysschaert, M. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70836-3
Oncology adapted nutritional support: A role for low glycemic medical nutrition
Bhaskaran, K., Hussain, S. S. B., & van Helvoort, A. (2014) · PharmaNutrition · doi:10.1016/j.phanu.2013.11.106
Yılmaz, H., Karadeniz, T., & Karadeniz, M. (2013)
Dias, E. O. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-24022015-110719
Durlach, V. (2011) · Médecine thérapeutique · doi:10.1684/met.2011.0332
Einfluss einer Ernährungsintervention auf prädiktive Tumormarker in Typ 2 Diabetikern
Stieglmayer, R. (2011) · University of Vienna · doi:10.25365/thesis.17339
Hewala, T. I., Ebeid, S. A., Saad, E.-S., Moneim, N. A. A. E., & Samir, M. (2015) · European Scientific Journal ESJ
Diabetes mellitus: A risk factor for cancer and non-vascular disease deaths too
Awasthi, S., Morris, S. K., Malhotra, S., & ZODPEY, S. P. (2011)
Association Between Glucose Tolerance Level and Cancer Death in a General
Hirakawa, Y., Ninomiya, T., Mukai, N., Doi, Y., Hata, J., Fukuhara, M., Iwase, M., Kitazono, T., & Kiyohara, Y. (2012)
González, D. C. F. (2012) · Revista de Endocrinología y Nutrición
Kumar, R., Sinha, A. K., Vijayakumar, M., Pandey, V., Bhide, A., Javadekar, S. S., Pawar, B., & Bhat, M. K. (2013)
Berstein, L. M., Teslenko, S. Y., Vasilyev, D. A., & Kovalenko, I. M. (2015) · Diabetes Mellitus · doi:10.14341/dm2015377-84
The Disrupted Steady-State: Tipping the Balance in Favour of Cancer
Linher‐Melville, K., & Singh, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-28558-0_1 · Cited by 1
“Numerous meta-analyses and research-based studies have indicated that the risk for developing several types of cancer, including liver, pancreatic, kidney, bladder, colorectal, breast, and endometrial, as well as non-Hodgkin’s lymphoma, is higher in patients with diabetes, with the strongest association reported for l…”
BackgroundJakubowicz, S. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.11144/javeriana.umed56-4.pmpc
Obermair, F., Popper, U., Romeder, F., & Rumpold, H. F. (2016) · Wiener klinisches Magazin · doi:10.1007/s00740-016-0107-4 · Cited by 1
Diabets and the incidence of cancer in a Portuguese urban cohort
Barros, S. R. M. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/thz6-m088
Type I Insulin-Like Growth Factor Receptor
Yee, D. (2017) · Springer eBooks · doi:10.1007/978-1-4419-0717-2_3
Prevention of Chronic Conditions and Cancer
McCarthy, A. L., Skinner, T. L., Fenech, M. F., & Keating, S. E. (2016) · Springer eBooks · doi:10.1007/978-981-10-1844-2_7
Mannucci, E., & Perriello, G. (2012)
Ruiter, R. (2016) · Journal of Diabetes and Obesity · doi:10.15436/2376-0494.16.1007
Schofield, C. J. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Viero, F. T., & Lara, J. M. (2015) · XX SALÃO DE INICIAÇÃO CIENTÍFICA E TECNOLÓGICA
Oota, M. (2018) · Journal of Clinical and Translational Endocrinology Case Reports · doi:10.1016/j.jecr.2018.07.001
Comorbidity in Aging and Cancer
Ramsdale, E. E., Zittel, J., & Sarfati, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-44870-1_54-1
Phytochemicalsin Cancer Management
Thomas, R., Yang, D. D., Zollman, C., & Williams, M. M. A. (2017) · Current Research in Complementary & Alternative Medicine · doi:10.29011/2577-2201/100005
Insight in disease and drug interactions, with treatment optimisation of patients with cancer
Knapen (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190510lk
ANALOGHI DELL’INSULINA E CANCRO
Sciacca, L., & Milluzzo, A. (2019) · il Diabete · doi:10.30682/ildia1901b
Routine HbA1c among hematology and oncology inpatients: Diabetes-status and hospital-outcomes
Chiu, W.-L., Churilov, L. P., Lim, C.-H., Tan, A., Nedumannil, R., Lau, L., Lew, J., Hachem, M., Kong, A., Robbins, R., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.002
Krajewska, J., Krajewski, W. R., & Zatoński, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_59
Glycemic Variation and Cancer Occurrence—A New Paradigm
Sharma, R. (2019) · The Cancer Journal · doi:10.1097/ppo.0000000000000388
Diabetes with Pancreatic Ductal Adenocarcinoma
Srivani, G., Dariya, B., Alam, A., & Nagaraju, G. P. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_7
Kayingo, G., & Hass, V. M. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.12.002
Wang, J.-H., Pan, C.-H., Chen, Y., & Chang, I. (2020) · Emerging topics in statistics and biostatistics · doi:10.1007/978-3-030-33416-1_17
Diyabetes Mellitus Ağız Kanserleri İçin Bir Risk Faktörü Mü?
Başaran, M. (2020) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.771272
Malignancy Concerns With Antidiabetic Therapies: Examining the Evidence
Lebovitz, H. E. (2010) · Endocrine Practice · doi:10.1016/s1530-891x(20)42872-1
La terapia insulinica nel diabete mellito tipo 2
Prato, S. D., Sesti, G., Bonadonna, R. C., Consoli, A., Dotta, F., Fanelli, C. G., Mannucci, E., Miccoli, R., Pontiroli, A. E., Pozzilli, P., et al. (2011) · CINECA IRIS Institutial research information system (University of Pisa)
Glucocorticoid-induced hyperglycemia in oncohematological patients
Shabana, H., Bazeed, M., Nayel, H., Attia, M., & Elwan, M. (2020) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_63_19
The Link between Cancer, Autoimmunity and DiabetesPreprint
Petrić, D. (2021) · doi:10.14293/s2199-1006.1.sor-.ppxal5b.v1
Diabetesremission durch metabolische Chirurgie
Schernthaner, G.-H., Kopp, H.-P., Brix, J., & Schernthaner, G.-H. (2010) · Der Diabetologe · doi:10.1007/s11428-010-0623-6
Hyperglykämie und Onkogenese: Krebsrisiko unterschätzt
Riemann, J. F. (2017) · Deutsches Ärzteblatt · doi:10.3238/persdia.2017.10.13.03
Comorbidity in Aging and Cancer
Ramsdale, E. E., Zittel, J., & Sarfati, D. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_54
Paraneoplastic Syndromes in Pancreatic Cancer
Werner, J., & Herzig, S. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_27-2
Yee, D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_4-2
Research Status and Prospect of Metabolic Abnormalities in Hepatocellular Carcinoma
祁, 峰. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.116394
Type I Insulin-Like Growth Factor Receptor
Yee, D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_3-2
Gaba, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-48662-8_1
Type 2 Diabetes Mellitus with Plantar Malignant Melanoma: Report of Two Cases and Literature ReviewPreprint
Huang, B.-L., Tan, M., Liang, J., Li, M., Liao, L., Zhou, M., & Wang, M. (2021) · Research Square · doi:10.21203/rs.3.rs-318639/v1
Nwabudike, L. C., Oproiu, A. M., Dogaru, I. M., Costache, M., & Tatu, A. L. (2022) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s361793
Bright, T. M. (2022) · Contemporary Endocrinology · doi:10.1007/978-3-031-16258-9_10
Han, J. E., Park, M., Jin, J., Lee, J.-A., Park, G., Park, J. S., Bae, H.-I., Yun, S., Seo, A., Han, M.-H., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093080
“However, participants with diabetes are not “healthy” and could affect the outcome of a cancer biomarker study because diabetes has been known to increase overall cancer risk [4].”
BackgroundAssessing the Effect of Cancer Diagnosis on Beliefs about Comorbid Diabetes
Muellers, K., Harris, Y., Wisnivesky, J. P., & Lin, J. J. (2023) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2023.151436
Wojciechowska, J. K., Krajewski, W. R., Zatoński, T., & Rodríguez‐Saldaña, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_63
A Mendelian randomization study of type 2 diabetes on prostate cancerPreprint
Guo, H., Deng, J., Niu, X., Sun, Y., Huang, F., & Chen, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3302364/v1
Zhou, W., Cheng, Y., Chen, J., Chen, H., Wang, M., Cao, W., He, C., Zhao, Q., Zhang, P., Wang, W. T., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3421705/v1
“PLANT BASED-DIET”: TRATAMENTO PARA DIABETES MELLITUS 2
Oliveira, L. M. M. D., Teixeira, B. B. D. S., & Leão, F. M. (2023) · Revista Contemporânea · doi:10.56083/rcv3n12-101
Pathomechanismen von Diabetes und Krebs
Klühs, C. (2024) · Diabetes aktuell · doi:10.1055/a-2252-5874
Gao, X., Qian, J., Zhang, Y., Wang, H., Cui, J., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24186043
Gao, X., Qian, J., Zhang, Y., Wang, H., Cui, J., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24186046
Mechanistic and Clinical Chemoprevention
Moerland, J. A., Chowdhury, A. S., Occhiuto, C. J., Hung, P., & Liby, K. T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00058-9
The predictions of seven cancers burden attributed to high fasting plasma glucose from 2020 to 2030Preprint
Ye, J., Wang, P., Qin, J., Lei, F., Tang, F., Lin, L., Zhang, X., Wang, W., Liu, W., Chen, Z., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4369129/v1
Association Between Primary Open Angle Glaucoma and Type II Diabetes Mellitus in Benghazi, Libya
Emgory, T., & Gibril, A. (2024) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.2472024
“[9 –11].”
Bai, X., & Zhang, L. (2024) · medRxiv · doi:10.1101/2024.07.19.24310599
Cypress, M. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.ch32
Daniel, J. M. M., Mathiazhagan, G., & Sathick, I. J. (2024) · Springer eBooks · doi:10.1007/978-981-97-6406-8_18
Hansen, K., Peters, K., Burkert, C. K., Brose, E., Calvisi, D. F., Ehricke, K., Engeler, M., Knuth, E., Kröger, N., Löhr, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111438
“The increased risk of developing tumors in diabetes mellitus might be due to an upregulation of the proliferative pathway of insulin signaling in the setting of hyperglycemia and insulin resistance [21].”
BackgroundNutrition for Cancer Prevention and Therapy
Vela, V., Sabani, B., & Spahn, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-84297-9_8
Prognostic Model for Breast Cancer Based on Blood Glucose-Related Genes in Different Subtypes
吴, 南. (2025) · Advances in Applied Mathematics · doi:10.12677/aam.2025.144184
ALGhabra, Y., Hamdi, M., & Yousfan, A. (2025) · Acta Oto-Laryngologica Case Reports · doi:10.1080/23772484.2025.2509660
Ernährung zur Krebsprävention und -therapie
Vela, V., & Spahn, G. (2025) · Springer eBooks · doi:10.1007/978-3-662-70291-8_8
Distinct somatic mutation profiles in colon cancer by behavioral comorbidity
Cuomo, R. E. (2025) · Future Science OA · doi:10.1080/20565623.2025.2561501
Starving Cancer: How Glucose Restriction Enhances Tamoxifen sensitivity in Breast CancerPreprint
Lafta, H. Y., Fallahi, H., & Sabbah, M. A. (2025) · Research Square · doi:10.21203/rs.3.rs-7668101/v1
Li, J., Liu, J., Cai, B., & Yang, C. (2025) · BMC Cancer · doi:10.1186/s12885-025-15340-0
Wu, S., Huo, H., Liu, Y., Shi, X., Liu, C., Zha, H., & Shi, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-03640-x
Sung, K.-H., Yu, J. S., Kim, S., Kim, M. K., Park, Y., Han, K., & Lee, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70388
Rôle du système IGF-1/insuline dans le Myélome Multiple
Sprynski, A. C. (2009) · HAL
Gao, X., Qian, J., Zhang, Y., Wang, H., Cui, J., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24186040
Gao, X., Qian, J., Zhang, Y., Wang, H., Cui, J., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24186037
Gao, X., Qian, J., Zhang, Y., Wang, H., 崔杰峰, & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24186052
Gao, X., Qian, J., Zhang, Y., Wang, H., 崔杰峰, & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24186049
Das, M., Kiruthiga, C., Kamaladevi, A., & Kulanthaivel, L. (2026) · Springer eBooks · doi:10.1007/978-981-95-5651-9_4
Javed, S., Javed, U., Noor, D. A. M., Hanafiah, N. H. M., Mustafa, T., Rehman, A. U., & Harun, S. N. (2026) · PLoS ONE · doi:10.1371/journal.pone.0319314
“The rising trend and variability in blood glucose suggest that more aggressive interventions, such as insulin therapy or adjustments in diabetes management, may be necessary to avoid complications in this group [20].”
Investigating the Role of Insulin and Its Analogs in Breast Cancer Proliferation
Garg, N., Kamal, C. M., & Chander, H. (2026) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-026-10821-7
(2020) · PubMed Central · Cited by 12
Metadata
- Authors
- Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R.
- Affiliations
- Section of General Pathology 1
- University of Catania (IT)
- Corresponding author
- Vigneri, Paolo
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2009-12-01
- Volume
- 16
- Issue
- 4
- Pages
- 1103-1123
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2163691729
- Cited by
- 1,009
- References
- 183
- Citations by year
- 2026: 20 · 2025: 43 · 2024: 54 · 2023: 49 · 2022: 49 · 2021: 46 · 2020: 50 · 2019: 57 · 2018: 60 · 2017: 75 · 2016: 59 · 2015: 68 · 2014: 85 · 2013: 97 · 2012: 80
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Related Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- diabetes mellitus, cancer risk, hyperinsulinemia, insulin-like growth factor I, insulin receptor, metformin, antidiabetic drugs, glucocorticoids, androgen receptor antagonists, obesity, hyperglycemia, oxidative stress, pancreatic cancer, liver cancer, breast cancer, colorectal cancer, cancer mortality, confounding factors
- MeSH terms
- Humans, Neoplasms, Risk Factors, Survival Rate, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
